Your browser doesn't support javascript.
loading
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci, Ozge; Kaymak, Aysegul; Raza, Umar; Ersan, Pelin G; Akbulut, Ozge; Banister, Carolyn E; Sikirzhytski, Vitali; Tokat, Unal Metin; Aykut, Gamze; Ansari, Suhail A; Dogan, Hayriye Tatli; Dogan, Mehmet; Jandaghi, Pouria; Isik, Aynur; Gundogdu, Fatma; Kosemehmetoglu, Kemal; Dizdar, Omer; Aksoy, Sercan; Akyol, Aytekin; Uner, Aysegul; Buckhaults, Phillip J; Riazalhosseini, Yasser; Sahin, Ozgur.
Afiliação
  • Saatci O; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, 29208, USA.
  • Kaymak A; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, 29208, USA.
  • Raza U; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Ersan PG; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Akbulut O; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Banister CE; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, 29208, USA.
  • Sikirzhytski V; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, 29208, USA.
  • Tokat UM; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Aykut G; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Ansari SA; Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, 06800, Ankara, Turkey.
  • Dogan HT; Department of Medical Pathology, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
  • Dogan M; Department of Medical Pathology, Ankara Oncology Education and Research Hospital, 06200, Ankara, Turkey.
  • Jandaghi P; Department of Human Genetics, McGill University, Montreal, QC, H3A 1B1, Canada.
  • Isik A; McGill University and Genome Quebec Innovation Centre, Montreal, QC, H3A 0G1, Canada.
  • Gundogdu F; Hacettepe University Transgenic Animal Technologies Research and Application Center, 06100, Ankara, Turkey.
  • Kosemehmetoglu K; Faculty of Medicine, Department of Pathology, Hacettepe University, 06100, Ankara, Turkey.
  • Dizdar O; Faculty of Medicine, Department of Pathology, Hacettepe University, 06100, Ankara, Turkey.
  • Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100, Ankara, Turkey.
  • Akyol A; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100, Ankara, Turkey.
  • Uner A; Hacettepe University Transgenic Animal Technologies Research and Application Center, 06100, Ankara, Turkey.
  • Buckhaults PJ; Faculty of Medicine, Department of Pathology, Hacettepe University, 06100, Ankara, Turkey.
  • Riazalhosseini Y; Faculty of Medicine, Department of Pathology, Hacettepe University, 06100, Ankara, Turkey.
  • Sahin O; Hacettepe University Molecular Pathology Research and Application Center, 06100, Ankara, Turkey.
Nat Commun ; 11(1): 2416, 2020 05 15.
Article em En | MEDLINE | ID: mdl-32415208
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Neoplasias de Mama Triplo Negativas / Proteína-Lisina 6-Oxidase / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Neoplasias de Mama Triplo Negativas / Proteína-Lisina 6-Oxidase / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos